According to a recent LinkedIn post from Monarch Medical Technologies, the company is emphasizing a clinician-led implementation model for its EndoTool insulin dosing platform in hospital settings. The post highlights that onboarding is guided by clinical experts from the Glooko team with bedside experience, rather than generic technology staff.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that hospitals adopting EndoTool receive dedicated clinical, technical, and project resources, including training led by nurses who have used the platform in practice and long-term support aligned with system goals. For investors, this focus on clinically driven implementation and ongoing support may strengthen customer retention, differentiate EndoTool in the glycemic management niche, and potentially support pricing power and expansion across hospital networks.